As a leader who has committed much of his career to improving healthcare — an industry that holds millions of people’s lives ...

Monica Vajani, Executive Director for mHUB’s MedTech Accelerator, discusses how mHUB is helping innovators transition healthcare towards value-based care. These strategies and practices can ...

There’s no escaping AI – try as we all did at HLTH – but Brook Health’s plan is to use AI to extend the primary care provider’s relationship to the patient’s home for chronic disease ...

Upstream Bio will use its IPO haul to continue clinical testing of verekitug, which it contends could be a better treatment option for severe asthma compared to a commercialized Amgen and ...

Eli Lilly’s Jaypirca is now approved for treating three types of blood cancers. While Jaypirca blocks a target already addressed by other cancer therapies, the Lilly molecule does it in a way ...

Katie Adams is a senior reporter for MedCity News covering providers and healthcare technology. Previously, she worked as a healthcare technology editor at Becker’s Hospital Review. Her ...

Chicago-based Rush University System for Health recently struck a partnership with Cadence — the health system is beginning an RPM pilot using the startup's technology platform and clinicians.

Hurdle wants to address mental healthcare for minority populations whose problems are not well-addressed by the prevalent healthcare infrastructures. Learn about cultural humility (not cultural ...

Archon Biosciences’ antibody cages change the structure of an antibody to control how a drug distributes in the body. The startup comes from the lab of David Baker, the University of Washington ...

At a time when the healthcare industry is battling point solution fatigue, it begs the question: is there still a place for all these solutions? According to one industry executive —Doba ...

Make no mistake: the hype surrounding generative AI in the healthcare sector is still going strong. Overall, the industry is excited about the technology’s potential to alleviate burnout ...

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million ...